Drug intelligence / Profile preview

Glycolix Glyco-Urea KP Therapy

Development stage
Unknown
Lead developer
Topix Pharmaceuticals
Modality
Small Molecules
Administration
Topical
01

Overview

Glycolix Glyco-Urea KP Therapy is a topical skincare cream developed and launched by Topix Pharmaceuticals in May 2018. The product is a combination therapy containing 15% glycolic acid and 15% urea, specifically formulated to treat hyperkeratotic skin conditions such as keratosis pilaris (KP), psoriasis, and dermatitis. Glycolic acid, an alpha-hydroxy acid, acts as a chemical exfoliant to remove dead skin cells and smooth skin texture. Urea serves as a potent humectant that moisturizes and replenishes the skin barrier. The formulation utilizes a patented technology that allows its 15% urea concentration to achieve exfoliation efficacy comparable to 40% urea. Additionally, the cream contains proteolytic enzymes to assist in scale removal and hyaluronic acid to bind moisture to the skin. It is designed for twice-daily application, with therapeutic results typically observed within two weeks.

Brand names
Glycolix Glyco-Urea KP Therapy
Other names
Glycolic Acid 15% + Urea 15% OintmentAlpha Hydroxy Acid + Urea Ointment

Beyond the preview

Go deeper on Glycolix Glyco-Urea KP Therapy.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycolix Glyco-Urea KP Therapy.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call